OMNIAB, INC. Payments of Stock Issuance Costs
OMNIAB, INC. (OABI) reported Payments of Stock Issuance Costs of $698.10 thousand for the 11-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-11-10
- 2021-12-31: Payments of Stock Issuance Costs 11 month $698.10K.
- 2021-09-30: Payments of Stock Issuance Costs 8 month $615.69K.
- 2021-06-30: Payments of Stock Issuance Costs 5 month $83.13K.
| Period end | Payments of Stock Issuance Costs 5 month | Payments of Stock Issuance Costs 8 month | Payments of Stock Issuance Costs 11 month |
|---|---|---|---|
| 2021-12-31 | $698.10K 10-K · filed 2022-03-28 | ||
| 2021-09-30 | $615.69K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $83.13K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |